Schond L. Greenway net worth and biography

Schond Greenway Biography and Net Worth

Schond Greenway is the CFO of Mind Medicine (MindMed).

What is Schond L. Greenway's net worth?: The estimated net worth of Schond L. Greenway is at least $2.69 million as of December 26th, 2023. Greenway owns 216,617 shares of Mind Medicine (MindMed) stock worth more than $2,692,549 as of December 4th. This net worth evaluation does not reflect any other assets that Greenway may own. Learn More about Schond L. Greenway's net worth.
How do I contact Schond L. Greenway?: The corporate mailing address for Greenway and other Mind Medicine (MindMed) executives is , , . Mind Medicine (MindMed) can also be reached via phone at 650-208-2454 and via email at [email protected]. Learn More on Schond L. Greenway's contact information.
Has Schond L. Greenway been buying or selling shares of Mind Medicine (MindMed)?: Schond L. Greenway has not been actively trading shares of Mind Medicine (MindMed) within the last three months. Most recently, Schond L. Greenway sold 5,652 shares of the business's stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $3.63, for a transaction totalling $20,516.76. Following the completion of the sale, the chief financial officer now directly owns 216,617 shares of the company's stock, valued at $786,319.71. Learn More on Schond L. Greenway's trading history.
Who are Mind Medicine (MindMed)'s active insiders?: Mind Medicine (MindMed)'s insider roster includes Robert Barrow (Chief Executive Officer and Board Director), Schond Greenway (CFO), David Gryska (Director), Dan Karlin (Insider), Daniel Karlin (Insider), Carrie Liao (CAO), and Mark Sullivan (Insider). Learn More on Mind Medicine (MindMed)'s active insiders.
Are insiders buying or selling shares of Mind Medicine (MindMed)?: During the last twelve months, insiders at the sold shares 12 times. They sold a total of 149,022 shares worth more than $1,162,173.63. The most recent insider tranaction occured on September, 25th when insider Mark Sullivan sold 11,278 shares worth more than $110,186.06. Insiders at Mind Medicine (MindMed) own 2.5% of the company. Learn More about insider trades at Mind Medicine (MindMed).
Information on this page was last updated on 9/25/2025.

Schond L. Greenway Insider Trading History at Mind Medicine (MindMed)

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/26/2023	Sell	5,652	$3.63	$20,516.76	216,617
9/25/2023	Sell	5,762	$3.58	$20,627.96	222,269
8/25/2023	Sell	20,000	$3.80	$76,000.00	228,031
6/27/2023	Sell	11,635	$3.20	$37,232.00	248,031

Schond L. Greenway Buying and Selling Activity at Mind Medicine (MindMed)

Mind Medicine (MindMed) Company Overview

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Today's Range

Now: $12.43

$11.80

$12.55

50 Day Range

MA: $12.16

$10.67

$14.20

2 Week Range

Now: $12.43

$4.70

$14.43

Volume

1,199,690 shs

Average Volume

1,427,440 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57